Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Open accessThe DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Abstract
The autoimmune disease immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is caused by mutations in the forkhead box protein P3 (FOXP3) gene. In the mouse model of FOXP3 deficiency, the lack of CD4+ CD25+ Tregs is responsible for lethal autoimmunity, indicating that FOXP3 is required for the differentiation of this Treg subset. We show that the number and phenotype of CD4+ CD25+ T cells from IPEX patients are comparable to those of normal donors. CD4+ CD25high T cells from IPEX patients who express FOXP3 protein suppressed the in vitro proliferation of effector T cells from normal donors, when activated by "weak" TCR stimuli. In contrast, the suppressive function of CD4+ CD25high T cells from IPEX patients who do not express FOXP3 protein was profoundly impaired. Importantly, CD4+ CD25high T cells from either FOXP3+ or FOXP3- IPEX patients showed altered suppression toward autologous effector T cells. Interestingly, IL-2 and IFN-gamma production by PBMCs from IPEX patients was significantly decreased. These findings indicate that FOXP3 mutations in IPEX patients result in heterogeneous biological abnormalities, leading not necessarily to a lack of differentiation of CD4+ CD25high Tregs but rather to a dysfunction in these cells and in effector T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Loss of function mutations of Foxp3 lead to the manifestation of the scurfy phenotype in mice, corresponding to the IPEX-syndrome in humans [434].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [434]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Cited by
Items 101–200 of 509
Moving to tolerance: Clinical application of T regulatory cells
McMurchy, A. N., Bushell, A., Levings, M. K., & Wood, K. J. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.04.001 · Cited by 109
“2 Adaptive Treg—Broadly speaking, the CD4+ T cell compartment of rodents and man contains approximately 5-10% of FOXP3+ nTreg and, as discussed earlier, these clearly play an essential role in normal immune homeostasis [10-12, 14, 89-91].”
BackgroundTGF-β in tolerance, development and regulation of immunity
Johnston, C. J. C., Smyth, D. J., Dresser, D. W., & Maizels, R. M. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.10.006 · Cited by 120
“Tregs are crucial for physiological immune homeostasis and their absence leads to severe autoimmunity, which is universally fatal in ‘scurfy’ mice that lack Foxp3 expression [45] and manifests as a life-limiting multisystem disorder in humans – the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndro…”
BackgroundSingh, R. P., Cava, A. L., Wong, M., Ebling, F. M., & Hahn, B. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7649 · Cited by 101
Missé, D., Yssel, H., Trabattoni, D., Oblet, C., Caputo, S. L., Mazzotta, F., Pène, J., Gonzalez, J., Clerici, M., & Veas, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.407 · Cited by 99
“1 g/ml PHA (Roche Diagnostics) and were propagated with rIL-2 (2 ng/ml; Diaclone Research) as described (14, 15).”
MethodJacobse, J., Li, J., Rings, E. H. H. M., Samsom, J. N., & Goettel, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716499 · Cited by 109
Regulatory T cells for tolerance
Kawai, K., Uchiyama, M., Hester, J., Wood, K. J., & Issa, F. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.12.013 · Cited by 103
“In a similar manner, a FOXP3 mutation in humans leads to an X-linked autoimmune lymphoproliferative disorder called immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) [9].”
Subcellular localization of FOXP 3 in human regulatory and nonregulatory T cells
Magg, T., Mannert, J., Ellwart, J. W., Schmid, I., & Albert, M. H. (2012) · European Journal of Immunology · doi:10.1002/eji.201141838 · Cited by 114
Hyaluronan in immune dysregulation and autoimmune diseases
Nagy, N., Kuipers, H. F., Marshall, P. L., Wang, E., Kaber, G., & Bollyky, P. L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.022 · Cited by 97
Dotan, I., Allez, M., Danese, S., Keir, M. E., Tole, S., & McBride, J. (2019) · Medicinal Research Reviews · doi:10.1002/med.21601 · Cited by 113
Wang, Y. Y., Wang, Q., Sun, X., Liu, R., Shu, Y., Kanekura, T., Huang, J., Li, Y., Wang, J. C., Zhao, M., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.12913 · Cited by 90
Thymic Versus Induced Regulatory T Cells – Who Regulates the Regulators?
Povoleri, G. A. M., Scottà, C., Nova‐Lamperti, E., John, S., Lombardi, G., & Afzali, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00169 · Cited by 124
“Adaptive immune cells with regulatory function (“regulatory T-cells”) are essential to control Teffs.”
BackgroundInfluentialImmune Phenotype Predicts Risk for Posttransplantation Squamous Cell Carcinoma
Carroll, R. P., Segundo, D. S., Hollowood, K., Marafioti, T., Clark, T. G., Harden, P., & Wood, K. J. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060669 · Cited by 101
Hashimura, Y., Nozu, K., Kanegane, H., Miyawaki, T., Hayakawa, A., Yoshikawa, N., Nakanishi, K., Takemoto, M., Iijima, K., & Matsuo, M. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1119-8 · Cited by 88
“Mutations in the FOXP3 gene cause the IPEX syndrome [10], which is characterized by deficiency of Treg cell function, due to FOXP3 malfunction, highlighting the importance of FOXP3 in Treg cell development [6].”
BackgroundAdaptive Autoimmunity and Foxp3-Based Immunoregulation in Zebrafish
Quintana, F. J., Iglesias, A. H., Farez, M., Cáccamo, M., Burns, E. J., Kassam, N., Oukka, M., & Weiner, H. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009478 · Cited by 94
“autoimmune pathology in mice, and has been linked to the autoimmune syndrome immune dysregulation, polyendocrinopathy, enteropathy X-linked (IPEX) in humans [11,12,13,14,15,16].”
BackgroundT Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients
Libera, D. D., Mitri, D. D., Bergami, A., Centonze, D., Gasperini, C., Grasso, M. G., Galgani, S., Martinelli, V., Comı, G., Avolio, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021386 · Cited by 90
“Its mutation leads to a fatal autoimmune lymphoproliferative disease in both humans (IPEX syndrome) and mice (scurfy mice) [23] [24], and FoxP3 was demonstrated to largely control Tregs development and functional capacity [25,26].”
BackgroundHuman CD4 + FOXP3 + regulatory T cells produce CXCL8 and recruit neutrophils
Himmel, M. E., Crome, S. Q., Ivison, S. M., Piccirillo, C. A., Steiner, T. S., & Levings, M. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201040459 · Cited by 97
IPEX and the role of FOXP3 in the development and function of human Tregs
Bras, S. L. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28880 · Cited by 86
Ott, N., Faletti, L. E., Heeg, M., Andreani, V., & Grimbacher, B. (2023) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01483-x · Cited by 97
The battlefield of perforin/granzyme cell death pathways
Hoves, S., Trapani, J. A., & Voskoboinik, I. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909608 · Cited by 87
Autoimmune Polyendocrine Syndromes: Clues to Type 1 Diabetes Pathogenesis
Husebye, E. S., & Anderson, M. S. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.016 · Cited by 83
Passerini, L., Di Nunzio, S., Gregori, S., Gambineri, E., Cecconi, M., Seidel, M. G., Cazzola, G., Perroni, L., Tommasini, A., Vignola, S., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201040909 · Cited by 83
Self-citationT regulatory cell chemokine production mediates pathogenic T cell attraction and suppression
Patterson, S. J., Pesenacker, A. M., Wang, A. Y., Gillies, J. K., Mojibian, M., Morishita, K. A., Tan, R., Kieffer, T. J., Verchere, C. B., Panagiotopoulos, C., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83987 · Cited by 89
Engela, A. U., Baan, C. C., Dor, F. J. M. F., Weimar, W., & Hoogduijn, M. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00126 · Cited by 82
“IPEX patients lack functional Treg as a result of a point mutation in the Foxp3 gene (Bacchetta et al., 2006).”
BackgroundFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies
Abraham, R. S., & Aubert, G. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00001-16 · Cited by 93
Immune tolerance: mechanisms and application in clinical transplantation
Sykes, M. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01855.x · Cited by 91
Clinical tolerance in allogeneic hematopoietic stem cell transplantation
Roncarolo, M., Gregori, S., Lucarelli, B., Ciceri, F., & Bacchetta, R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01010.x · Cited by 88
“immune disease immunedysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, in which nTreg cells are dysfunctional because of mutations in the forkhead box protein-3 (FOXP3) gene (91).”
BackgroundSelf-citationT cell‐mediated immunoregulation in the gastrointestinal tract
Saurer, L., & Mueller, C. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.01965.x · Cited by 89
“However, unlike the Foxp3 mutant scurfy mice, human IPEX patients have a less severe and more heterogeneous phenotype depending on the site of the particular mutation in the FOXP3 gene (37).”
BackgroundA novel function for FOXP3 in humans: intrinsic regulation of conventional T cells
McMurchy, A. N., Gillies, J., Gizzi, M. C., Riba, M., Garcia-Manteiga, J. M., Cittaro, D., Lazarevic, D., Di Nunzio, S., Piras, I. S., Bulfone, A., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431023 · Cited by 77
Self-citationSeidel, M. G., Fritsch, G., Lion, T., Jürgens, B., Heitger, A., Bacchetta, R., Lawitschka, Á., Peters, C., Gadner, H., & Matthes‐Martin, S. (2009) · Blood · doi:10.1182/blood-2009-02-206359 · Cited by 77
Self-citationRosenberg, J. M., Maccari, M. E., Barzaghi, F., Allenspach, E. J., Pignata, C., Weber, G., Torgerson, T. R., Utz, P. J., & Bacchetta, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00544 · Cited by 77
“In IPEX patients, T effector cells (Teff) can become activated in the absence of the tolerizing functions of Treg leading to autoimmunity (20).”
BackgroundSelf-citationJandus, C., Bioley, G., Speiser, D. E., & Romero, P. J. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0507-4 · Cited by 76
“polyendocrinopathy, and enteropathy [6, 8].”
FOXP3: Genetic and epigenetic implications for autoimmunity
Katoh, H., Zheng, P., & Liu, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.004 · Cited by 73
Adurthi, S., Kumar, M. M., Vinodkumar, H. S., Mukherjee, G., Krishnamurthy, H., Kshitish, A. K., Bafna, U. D., Uma, D. K., Basavarajegowda, A., Krishna, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17102-w · Cited by 78
Autoantibodies to Harmonin and Villin Are Diagnostic Markers in Children with IPEX Syndrome
Lampasona, V., Passerini, L., Barzaghi, F., Lombardoni, C., Bazzigaluppi, E., Brigatti, C., Bacchetta, R., & Bosi, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078664 · Cited by 84
“So far, IPEX has been considered a T-cell, namely Treg-celldysfunction immune disease [18,36,37], with limited attention paid to associated defects of the humoral immune response: our findings highlight the association of the underlying FOXP3 gene mutations with a robust and quantitatively measurable antigenspecific a…”
BackgroundSelf-citationHigh frequency and proliferation of CD4+FOXP3+ Treg in HIV‐1‐infected patients with low CD4 counts
Bi, X., Suzuki, Y., Gatanaga, H., & Oka, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838667 · Cited by 73
Lahl, K., Mayer, C. T., Bopp, T., Huehn, J., Loddenkemper, C., Eberl, G., Wirnsberger, G., Dornmair, K., Geffers, R., Schmitt, E., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803762 · Cited by 75
Barzaghi, F., Passerini, L., Gambineri, E., Mannurita, S. C., Cornu, T. I., Kang, E., Choe, Y. H., Cancrini, C., Corrente, S., Ciccocioppo, R., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.12.009 · Cited by 76
“While in IPEX patients Treg cells, although present, are functionally impaired [4,8,20,21], the contribution of an altered Treg cell compartment in the pathogenesis of IPEX-like syndromes remains elusive.”
BackgroundMethodSelf-citationHelminths in the gastrointestinal tract as modulators of immunity and pathology
Varyani, F., Fleming, J. O., & Maizels, R. M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2017 · Cited by 91
“dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome) with extensive inflammation, particularly in the gastrointestinal tract (10).”
BackgroundPatients with CD3G mutations reveal a role for human CD3γ in Treg diversity and suppressive function
Rowe, J. H., Delmonte, O. M., Keles, S., Stadinski, B. D., Dobbs, K., Henderson, L. A., Yamazaki, Y., Allende, L. M., Bonilla, F. A., González‐Granado, L. I., et al. (2018) · Blood · doi:10.1182/blood-2018-02-835561 · Cited by 74
“IgA, mg/dL 20 (14-122) 180 (68-408) 18 (14-105) 6.”
Haas, O. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03136 · Cited by 81
Abron, J. D., Singh, N. P., Mishra, M. K., Price, R. L., Nagarkatti, M., Nagarkatti, P. S., & Singh, U. P. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00413.2017 · Cited by 70
Building a CAR-Treg: Going from the basic to the luxury model
Rosado‐Sánchez, I., & Levings, M. K. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104220 · Cited by 74
Jamee, M., Zaki‐Dizaji, M., Lo, B., Abolhassani, H., Aghamahdi, F., Moosavian, M., Nademi, Z., Mohammadi, H., Jadidi‐Niaragh, F., Rojas, M., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.04.070 · Cited by 74
Interaction between Adipose Tissue-Derived Mesenchymal Stem Cells and Regulatory T-Cells
Engela, A. U., Baan, C. C., Peeters, A. M. A., Weimar, W., & Hoogduijn, M. J. (2013) · Cell Transplantation · doi:10.3727/096368912x636984 · Cited by 69
“The influential role of Tregs on maintaining tolerance was observed in patients suffering from immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX); these patients lack functioning Tregs due to a point mutation in the Foxp3 gene (4,7,32).”
BackgroundExpansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapy
Pereira‐Santos, M. C., Baptista, A. P., Melo, A., Alves, R. R., Soares, R. S., Pedro, E., Pereira‐Barbosa, M., Victorino, R. M. M., & Sousa, A. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02887.x · Cited by 69
RETRACTED: Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth
Zorro Manrique, S., Duque Correa, M. A., Hoelzinger, D. B., Dominguez, A. L., Mirza, N., Lin, H.-H., Stein-Streilein, J., Gordon, S., & Lustgarten, J. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100730 · Cited by 67
RetractedChapter 2 How the Immune System Achieves Self–Nonself Discrimination During Adaptive Immunity
Jiang, H., & Chess, L. (2009) · Advances in immunology · doi:10.1016/s0065-2776(09)01202-4 · Cited by 88
Franckaert, D., Dooley, J., Roos, E., Floess, S., Huehn, J., Luche, H., Fehling, H. J., Liston, A., Linterman, M. A., & Schlenner, S. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.108 · Cited by 76
Epigenetics, autoimmunity and hematologic malignancies: A comprehensive review
Ngalamika, O., Zhang, Y., Yin, H., Zhao, M., Gershwin, M. E., & Lu, Q. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.09.002 · Cited by 71
Ward, F. J., Hall, A. M., Cairns, L. S., Leggat, A. S., Urbaniak, S. J., Vickers, M. A., & Barker, R. N. (2007) · Blood · doi:10.1182/blood-2007-07-101345 · Cited by 66
Bacchetta, R., Gregori, S., Serafini, G., Sartirana, C., Schulz, U., Zino, E., Tomiuk, S., Jansen, U., Ponzoni, M., Paties, C. T., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.025825 · Cited by 75
“Naturally occurring Tr (CD4CD25FOXP3) cells are generated in the thymus and express high levels of FOXP3, which is essential for their suppressive function.(1,2) Adaptive Tr1 cells are induced in the periphery in the presence of interleukin (IL)-10, secrete high levels of IL-10 in the absence of IL-4, and suppress T-c…”
BackgroundSelf-citationAutoimmunity in Immunodeficiency
Todoric, K., Koontz, J., Mattox, D. E., & Tarrant, T. K. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0350-3 · Cited by 63
“IPEX results from a defect in the transcription factor FoxP3, which is crucial to the development of T regulatory cells (Tregs) [3, 10, 12, 23, 35].”
Gene therapy for primary immunodeficiencies: Part 2
Aiuti, A., Bacchetta, R., Seger, R. A., VILLA, A. M., & Cavazzana, M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.07.012 · Cited by 79
Self-citationZemmour, D., Charbonnier, L., Léon, J., Six, E. M., Keleş, S., Delville, M., Benamar, M., Barış, S., Zuber, J., Chen, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00910-8 · Cited by 69
“Such cells have been reported in IPEX patients 26–28 , but we first adopted a more global approach to identify Treg-like cells, since expression of these two markers could be perturbed by FOXP3 deficiencies.”
Westerberg, L. S., Klein, C., & Snapper, S. B. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.10.004 · Cited by 64
IL-2 therapy in type 1 diabetes: “Trials” and tribulations
Long, S. A., Buckner, J. H., & Greenbaum, C. J. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.005 · Cited by 68
New Reagents on the Horizon for Immune Tolerance
St. Clair, E. W., Turka, L. A., Saxon, A., Matthews, J. B., Sayegh, M. H., Eisenbarth, G. S., & Bluestone, J. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145449 · Cited by 62
“In some of these patients, the effector CD4+CD25− T cells show reduced susceptibility to suppression (21).”
BackgroundTegtmeyer, D., Seidl, M., Gerner, P., Baumann, U., & Klemann, C. (2017) · Pediatric Allergy and Immunology · doi:10.1111/pai.12734 · Cited by 63
Ghelani, A. P., Bates, D. L., Conner, K. P., Wu, M.-Z., Lu, J., Hu, Y.-L., Li, C.-M., Chaudhry, A., & Sohn, S. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01106 · Cited by 65
“However, increasing the number of Treg cells may not be sufficient, based on the examples where the presence of (or even elevated numbers of) Treg cells does not result in reduced inflammation (52, 53).”
BackgroundSchlöder, J., Shahneh, F. Z., Schneider, F.-J., & Wieschendorf, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.973813 · Cited by 67
IPEX syndrome from diagnosis to cure, learning along the way
Bacchetta, R., & Roncarolo, M. G. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.11.021 · Cited by 66
Self-citationThe role of inflammation in progression of breast cancer: Friend or foe? (Review)
Allen, M. D., & Jones, J. L. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3075 · Cited by 74
Johnson, J. L., Jones, M. B., & Cobb, B. A. (2017) · Glycobiology · doi:10.1093/glycob/cwx093 · Cited by 66
“2006), the loss of functional FoxP3, whether through murine genetic manipulation or in the human disease called IPEX, results in severe autoimmune pathology (Bacchetta et al. 2006).”
BackgroundLin, Y., Hara, H., Tai, H., Long, C. E., Tokita, D., Yeh, P. C., Ayares, D., Morelli, A. E., & Cooper, D. K. C. (2008) · Transplantation · doi:10.1097/tp.0b013e318188acb0 · Cited by 60
“Recent studies demonstrating that FoxP3 expression in human Tregs does not precisely correlate with suppressive function partially support our finding of different levels of FoxP3 expression in activated human CD4 T cells (20, 65, 66).”
BackgroundRosewich, M., Schulze, J., Eickmeier, O., Telles, T., Rose, M. A., Schubert, R., & Zielen, S. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04106.x · Cited by 63
Otsubo, K., Kanegane, H., Kamachi, Y., Kobayashi, I., Tsuge, I., Imaizumi, M., Sasahara, Y., Hayakawa, A., Nozu, K., Iijima, K., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.06.006 · Cited by 62
Migration and homeostasis of regulatory T cells in rheumatoid arthritis
Kotschenreuther, K., Yan, S., & Kofler, D. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947636 · Cited by 67
“However, FoxP3 holds a pivotal role to regulatory T cell function, as evidenced by the X-Linked syndrome of immune dysregulation, polyendocrinopathy, and enteropathy (IPEX) caused by a mutation in the FoxP3 gene leading to large amounts of polyclonal T-cell activation and tissue infiltration (21, 22).”
BackgroundRegulatory T-cell development: is Foxp3 the decider?
Curiel, T. J. (2007) · Nature Medicine · doi:10.1038/nm0307-250 · Cited by 57
Human CD4 + HLA‐G + regulatory T cells are potent suppressors of graft‐versus‐host disease in vivo
Pankratz, S., Bittner, S., Herrmann, A. M., Schuhmann, M. K., Ruck, T., Meuth, S. G., & Wiendl, H. (2014) · The FASEB Journal · doi:10.1096/fj.14-251074 · Cited by 58
Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice
Zhao, H., Huang, X.-Y., Zuo, Z.-Q., Pan, Q.-H., Ao, M., Zhou, F., Liu, H., Liu, Z.-Y., & Liu, D. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i5.742 · Cited by 58
Autoimmunity and Primary Immunodeficiency Disorders
Allenspach, E. J., & Torgerson, T. R. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0294-1 · Cited by 57
“The classic disorder of Treg deficiency is immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) in which the absence of a functional FOXP3 transcription factor leads to aborted Treg development or Treg dysfunction [20–22].”
BackgroundThe biopsy pathology of non‐coeliac enteropathy
Greenson, J. K. (2014) · Histopathology · doi:10.1111/his.12522 · Cited by 55
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade
Huss, D. J., Mehta, D. S., Sharma, A., You, X., Riester, K. A., Sheridan, J. P., Amaravadi, L. S., Elkins, J. S., & Fontenot, J. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402140 · Cited by 57
IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis
Barzaghi, F., & Passerini, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.612760 · Cited by 55
“TCR repertoire is polyclonal, and the in vitro cytokine production shows a skew to a Th2-type profile (3, 26, 61).”
BackgroundJarvis, L. B., Rainbow, D. B., Coppard, V., Howlett, S., Georgieva, Z. G., Davies, J. L., Mullay, H. K., Hester, J., Ashmore, T., van den Bosch, A. M. R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02721-x · Cited by 242
Fodor, E. K., Garaczi, E., Polyánka, H., Koreck, A., Kemény, L. V., & Széll, M. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.06.011 · Cited by 56
Nunzio, S. D., Cecconi, M., Passerini, L., McMurchy, A. N., Baron, U., Türbachova, I., Vignola, S., Valencic, E., Tommasini, A., Junker, A., et al. (2009) · Blood · doi:10.1182/blood-2009-04-214593 · Cited by 54
Self-citationZhan, H., Sinclair, J., Adams, S. P., Cale, C. M., MURCH, S. H., Perroni, L., Davies, E. G., Amrolia, P. J., & Qasim, W. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1863 · Cited by 54
Functional Dynamics of Naturally Occurring Regulatory T Cells in Health and Autoimmunity
Levings, M. K., Allan, S., d'Hennezel, E. B., & Piccirillo, C. A. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)92003-3 · Cited by 60
Vazquez, S. E., Mann, S. A., Bodansky, A., Kung, A. F., Quandt, Z., Ferré, E. M. N., Landegren, N., Eriksson, D., Bastard, P., Zhang, S., et al. (2022) · eLife · doi:10.7554/elife.78550 · Cited by 56
Self-citationBaecher-Allan, C. M., Costantino, C. M., Cvetanovich, G. L., Ashley, C. W., Beriou, G., Dominguez-Villar, M., & Hafler, D. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002502 · Cited by 52
Atypical Presentations of IPEX: Expect the Unexpected
Consonni, F., Mannurita, S. C., & Gambineri, E. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.643094 · Cited by 45
Regulatory T-cell therapy approaches
McCallion, O., Bilici, M., Hester, J., & Issa, F. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac078 · Cited by 53
Okou, D. T., Mondal, K., Faubion, W. A., Kobrynski, L. J., Denson, L. A., Mulle, J. G., Ramachandran, D., Xiong, Y., Svingen, P. A., Patel, V., et al. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000302 · Cited by 51
Longhi, M. S., Ma, Y., Grant, C. R., Samyn, M., Gordon, P., Mieli‐Vergani, G., & Vergani, D. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.003 · Cited by 51
“That escalating degrees of immune-regulation impairment results in autoimmune manifestations of increasing severity is seen within the IPEX syndrome spectrum [24], where mutations of FOXP3 resulting in absence of the encoded protein are associated with severe disease manifestations, while mutations with a lower impact…”
BackgroundFetal-onset IPEX: Report of two families and review of literature
Xavier-da-Silva, M. M., Moreira‐Filho, C. A., Suzuki, E. K., Patrício, F. R. S., Coutinho, A., & Carneiro-Sampaio, M. M. S. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.12.007 · Cited by 50
McMurchy, A. N., Gillies, J. K., Allan, S., Passerini, L., Gambineri, E., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.001 · Cited by 50
Self-citationStratton, R. J., Slapak, G., Mahungu, T. W., & Loes, S. K. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283210006 · Cited by 55
Mizuno, T., Suzuki, R., Umeki, S., & Okuda, M. (2009) · Journal of Veterinary Medical Science · doi:10.1292/jvms.001561 · Cited by 49
“On the other hand, some patients who were diagnosed with immune dysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX), a severe autoimmune disease, have defective functions of Treg cells and harbor Foxp3 mutations [2, 3, 18], suggesting that peripheral immune tolerance in humans is regulated by a mecha…”
BackgroundInducing and Administering Tregs to Treat Human Disease
Perdigoto, A. L., Chatenoud, L., Bluestone, J. A., & Herold, K. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00654 · Cited by 49
From autoinflammation to autoimmunity: old and recent findings
Caso, F., Costa, L., Nucera, V., Barilaro, G., Masala, I. F., Talotta, R., Caso, P., Scarpa, R., Sarzi‐Puttini, P., & Atzeni, F. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4209-9 · Cited by 54
Immunopathogenesis of IBD: insufficient suppressor function in the gut?
Huibregtse, I. L., van Lent, A. U., & van Deventer, S. J. H. (2006) · Gut · doi:10.1136/gut.2006.103523 · Cited by 62
Long, S. A., Walker, M. R., Rieck, M., James, E., Kwok, W. W., Sanda, S., Pihoker, C., Greenbaum, C., Nepom, G. T., & Buckner, J. H. (2009) · European Journal of Immunology · doi:10.1002/eji.200838819 · Cited by 46
Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease
Leinwand, K. L., Jones, A. A., Huang, R. H., Jedlicka, P., Kao, D. J., de Zoeten, E. F., Ghosh, S., Moaddel, R., Wehkamp, J., Ostaff, M. J., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx096 · Cited by 45
Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope lipids and pathogenesis
Riley, L. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28734 · Cited by 58
Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice
Filipescu, I. E., Leonardi, L., Menchetti, L., Guelfi, G., Traina, G., Proietti, P. C., Piro, F., Quattrone, A., Barbato, O., & Brecchia, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202929 · Cited by 52
Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
Rodríguez, J. P., Murphy, M. P., Hong, S. J., Madrigal, M., March, K. L., Minev, B., Harman, R. J., Chen, C.-S., Timmons, R. B., Marleau, A. M., et al. (2012) · International Archives of Medicine · doi:10.1186/1755-7682-5-5 · Cited by 47
“The fundamental role of Treg in controlling immunity can be illustrated by the fact that genetic mutations associated with loss of Treg function, such as FoxP3 mutations, are associated with autoimmunity in mouse and man [91-93].”
BackgroundImmune Cell Infiltrate in Chronic-Active Antibody-Mediated Rejection
Sablik, K. A., Jordanova, E. S., Pocorni, N., Groningen, M. C. C., & Betjes, M. G. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03106 · Cited by 44
“Its presence in certain autoimmune diseases suggests an important role in immune tolerance (29, 30).”
BackgroundRuemmele, F. M., Moes, N. D., Patey, N., Rieux‐Laucat, F., & Goulet, O. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32830c9022 · Cited by 45
Epigenetic control of thymic Treg‐cell development
Kitagawa, Y., Ohkura, N., & Sakaguchi, S. (2014) · European Journal of Immunology · doi:10.1002/eji.201444577 · Cited by 44
Metadata
- Authors
- Bacchetta, R.
- Affiliations
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Corresponding author
- Bacchetta, R.
- ORCID
- Bacchetta, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1713-1722
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1472239
- OpenAlex
- W2095671247
- Cited by
- 511
- References
- 55
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 14 · 2023: 12 · 2022: 18 · 2021: 26 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 31 · 2016: 21 · 2015: 20 · 2014: 29 · 2013: 33 · 2012: 36
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Università degli Studi di Firenze
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI48779, R01AI048779)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- FOXP3 mutations, IPEX syndrome, regulatory T cells, CD4+CD25high T cells, Treg suppressive function, effector T cells, T cell proliferation inhibition, interleukin-2, interferon-gamma, autoimmunity
- MeSH terms
- Animals, Child, Preschool, Disease Models, Animal, Female, Humans, Infant, Interleukin-2, Leukocytes, Mononuclear, Male, Phenotype, Promoter Regions, Genetic, Protein-Losing Enteropathies, Biomarkers, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Cytokines, Polyendocrinopathies, Autoimmune, Jurkat Cells, Mutation, Missense, Genetic Diseases, X-Linked, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.